Tempus AI, Inc. is a technology company focused on leveraging artificial intelligence to revolutionize the healthcare industry
The company specializes in developing data-driven solutions that provide advanced analytics and insights for precision medicine, enhancing patient care by integrating clinical and molecular data. Tempus works with healthcare providers, researchers, and pharmaceutical companies to streamline the process of matching patients with tailored treatments, ultimately aiming to improve health outcomes and accelerate advancements in medical research. By harnessing the power of machine learning and vast datasets, Tempus is at the forefront of transforming healthcare practices and fostering innovation in the medical field.
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSEABBV), saying it's “just a gem” and a “winner.” He added, “I can't believe the stock dropped so much.”
Several AI-linked stocks are trading higher in Monday's after-hours session after Palantir Technologies shares rocketed higher on the back of blowout earnings. Here's what you need to know.
Tempus AI, Inc. (NASDAQTEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has completed its acquisition of Ambry Genetics, a recognized leader in genetic testing that aims to improve health by understanding the relationship between genetics and disease.
On Monday, we called for a trading bottom in healthcare stocks. We also saw momentum picking for two Health Science sectors: small- to mid-cap biotechs, and MedTech. Here is a closer look at these spaces.
Top performers in last week's mid-cap stocks: Oklo Inc., Tempus AI, Himax Tech, Super Group, NuScale Power, WNS Holdings, Guardant Health, Rigetti Computing.
Stocks surged higher as investors reacted positively to dovish tariff news; next week will be highlighted by the Federal Reserve meeting and some tech earnings
Tempus AI Inc (NASDAQTEM) shares are trading higher Wednesday. The stock appears to be moving on continued momentum from Tuesday's session. Here's a look at what you need to know.
TEM surged 35% on Tuesday, fueled by the launch of its AI-powered health app Olivia and news of Nancy Pelosi's disclosed call option position in the stock.
TempusAI’s olivia includes features such as smart profile summary, AI-enabled notetaker, medical image sharing, health monitoring and direct data import.
Tempus AI Inc (NASDAQTEM) shares are trading higher Tuesday after former House Speaker Nancy Pelosi disclosed a new position in the technology company.
Tempus AI, Inc. (NASDAQTEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of olivia. olivia is an AI-enabled personal health concierge app designed to empower patients by bringing their health-related data into one central location and leveraging advanced AI to provide actionable insights.
